BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 27150549)

  • 1. Loss of Hep Par 1 immunoreactivity in the livers of patients with carbamoyl phosphate synthetase 1 deficiency.
    Yamaguchi M; Kataoka TR; Shibayama T; Fukuda A; Nakazawa A; Minamiguchi S; Sakurai T; Miyagawa-Hayashino A; Yorifuji T; Kasahara M; Uemoto S; Haga H
    Pathol Int; 2016 Jun; 66(6):333-6. PubMed ID: 27150549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding carbamoyl phosphate synthetase (CPS1) deficiency by using the recombinantly purified human enzyme: effects of CPS1 mutations that concentrate in a central domain of unknown function.
    Díez-Fernández C; Hu L; Cervera J; Häberle J; Rubio V
    Mol Genet Metab; 2014 Jun; 112(2):123-32. PubMed ID: 24813853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular, biochemical, and clinical analyses of five patients with carbamoyl phosphate synthetase 1 deficiency.
    Fan L; Zhao J; Jiang L; Xie L; Ma J; Li X; Cheng M
    J Clin Lab Anal; 2020 Apr; 34(4):e23124. PubMed ID: 31749211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Study of Carbamoyl Phosphate Synthetase 1 Deficiency Sheds Light on the Mechanism for Switching On/Off the Urea Cycle.
    Díez-Fernández C; Gallego J; Häberle J; Cervera J; Rubio V
    J Genet Genomics; 2015 May; 42(5):249-60. PubMed ID: 26059772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbamoyl phosphate synthetase 1 deficiency in Italy: clinical and genetic findings in a heterogeneous cohort.
    Funghini S; Thusberg J; Spada M; Gasperini S; Parini R; Ventura L; Meli C; De Cosmo L; Sibilio M; Mooney SD; Guerrini R; Donati MA; Morrone A
    Gene; 2012 Feb; 493(2):228-34. PubMed ID: 22173106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Pathogenic Variant (c.580C>T) in the CPS1 Gene in a Newborn With Carbamoyl Phosphate Synthetase 1 Deficiency Identified by Whole Exome Sequencing.
    Choi R; Park HD; Yang M; Ki CS; Lee SY; Kim JW; Song J; Chang YS; Park WS
    Ann Lab Med; 2017 Jan; 37(1):58-62. PubMed ID: 27834067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular characterization of carbamoyl-phosphate synthetase (CPS1) deficiency using human recombinant CPS1 as a key tool.
    Diez-Fernandez C; Martínez AI; Pekkala S; Barcelona B; Pérez-Arellano I; Guadalajara AM; Summar M; Cervera J; Rubio V
    Hum Mutat; 2013 Aug; 34(8):1149-59. PubMed ID: 23649895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting CPS1 in the treatment of Carbamoyl phosphate synthetase 1 (CPS1) deficiency, a urea cycle disorder.
    Diez-Fernandez C; Häberle J
    Expert Opin Ther Targets; 2017 Apr; 21(4):391-399. PubMed ID: 28281899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two novel CPS1 mutations in a case of carbamoyl phosphate synthetase 1 deficiency causing hyperammonemia and leukodystrophy.
    Chen X; Yuan L; Sun M; Liu Q; Wu Y
    J Clin Lab Anal; 2018 Jun; 32(5):e22375. PubMed ID: 29314318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbamoyl phosphate synthetase 1 deficiency diagnosed by whole exome sequencing.
    Zhang G; Chen Y; Ju H; Bei F; Li J; Wang J; Sun J; Bu J
    J Clin Lab Anal; 2018 Feb; 32(2):. PubMed ID: 28444906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The antigen for Hep Par 1 antibody is the urea cycle enzyme carbamoyl phosphate synthetase 1.
    Butler SL; Dong H; Cardona D; Jia M; Zheng R; Zhu H; Crawford JM; Liu C
    Lab Invest; 2008 Jan; 88(1):78-88. PubMed ID: 18026163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conditional disruption of hepatic carbamoyl phosphate synthetase 1 in mice results in hyperammonemia without orotic aciduria and can be corrected by liver-directed gene therapy.
    Khoja S; Nitzahn M; Hermann K; Truong B; Borzone R; Willis B; Rudd M; Palmer DJ; Ng P; Brunetti-Pierri N; Lipshutz GS
    Mol Genet Metab; 2018 Aug; 124(4):243-253. PubMed ID: 29801986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding carbamoyl-phosphate synthetase I (CPS1) deficiency by using expression studies and structure-based analysis.
    Pekkala S; Martínez AI; Barcelona B; Yefimenko I; Finckh U; Rubio V; Cervera J
    Hum Mutat; 2010 Jul; 31(7):801-8. PubMed ID: 20578160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic, structural and biochemical basis of carbamoyl phosphate synthetase 1 deficiency.
    Martínez AI; Pérez-Arellano I; Pekkala S; Barcelona B; Cervera J
    Mol Genet Metab; 2010 Dec; 101(4):311-23. PubMed ID: 20800523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Living-donor liver transplantation for carbamoyl phosphate synthetase 1 deficiency.
    Kasahara M; Sakamoto S; Shigeta T; Fukuda A; Kosaki R; Nakazawa A; Uemoto S; Noda M; Naiki Y; Horikawa R
    Pediatr Transplant; 2010 Dec; 14(8):1036-40. PubMed ID: 21108709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatal hyperammonemia and carbamoyl phosphate synthetase 1 (CPS1) deficiency following high-dose chemotherapy and autologous hematopoietic stem cell transplantation.
    Laemmle A; Hahn D; Hu L; Rüfenacht V; Gautschi M; Leibundgut K; Nuoffer JM; Häberle J
    Mol Genet Metab; 2015 Mar; 114(3):438-44. PubMed ID: 25639153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of carbamoyl phosphate synthetase 1 deficiency presenting symptoms at one month of age.
    Ono H; Suto T; Kinoshita Y; Sakano T; Furue T; Ohta T
    Brain Dev; 2009 Nov; 31(10):779-81. PubMed ID: 19167850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and genetic analysis of a case of late onset carbamoyl phosphate synthase I deficiency caused by CPS1 mutation and literature review.
    Wang S; Chen J; Zhu X; Huang T; Xu H; Ying G; Qian H; Lin W; Tung Y; Khan KU; Guo H; Zheng G; Lu H; Zhang G
    BMC Med Genomics; 2023 Jun; 16(1):145. PubMed ID: 37365635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A liver-humanized mouse model of carbamoyl phosphate synthetase 1-deficiency.
    Srinivasan RC; Zabulica M; Hammarstedt C; Wu T; Gramignoli R; Kannisto K; Ellis E; Karadagi A; Fingerhut R; Allegri G; Rüfenacht V; Thöny B; Häberle J; Nuoffer JM; Strom SC
    J Inherit Metab Dis; 2019 Nov; 42(6):1054-1063. PubMed ID: 30843237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utilization of antihepatocyte clone OCH1E5 (Hep Par 1) in histological evaluation of liver tumors.
    Amarapurkar AD; Rege JD; Joshi AS; Vaiphei K; Amarapurkar DN
    Indian J Pathol Microbiol; 2006 Jul; 49(3):341-4. PubMed ID: 17001880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.